BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nardone G, Rocco A, Staibano S, Mezza E, Autiero G, Compare D, De Rosa G, Budillon G. Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther. 2005;22:1139-1146. [PMID: 16305728 DOI: 10.1111/j.1365-2036.2005.02734.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Grad C, Pop A, Gaborean E, Grad S, Dumitrascu D. Value of GastroPanel in the diagnosis of atrophic gastritis. Exp Ther Med 2021;22:1347. [PMID: 34630701 DOI: 10.3892/etm.2021.10782] [Reference Citation Analysis]
2 Liu H, Fei C, Zhang J. Associations of Serum Pepsinogens and Helicobacter Pylori Infection with High-Sensitivity C-Reactive Protein in Medical Examination Population. Lab Med 2021;52:57-63. [PMID: 32702129 DOI: 10.1093/labmed/lmaa042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Muhsen K, Sow SO, Tapia MD, Haidara FC, Reymann M, Asato V, Chen WH, Pasetti MF, Levine MM. Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults. Sci Rep 2020;10:16871. [PMID: 33037244 DOI: 10.1038/s41598-020-71754-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
4 Chapelle N, Petryszyn P, Blin J, Leroy M, Le Berre-Scoul C, Jirka I, Neunlist M, Moussata D, Lamarque D, Olivier R, Tougeron D, Mosnier JF, Matysiak-Budnik T. A panel of stomach-specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence area. Helicobacter 2020;25:e12727. [PMID: 32700438 DOI: 10.1111/hel.12727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Muhsen K, Sinnreich R, Merom D, Nassar H, Cohen D, Kark JD. Helicobacter pylori infection, serum pepsinogens as markers of atrophic gastritis, and leukocyte telomere length: a population-based study. Hum Genomics 2019;13:32. [PMID: 31331390 DOI: 10.1186/s40246-019-0217-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Bang CS, Lee JJ, Baik GH. Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. J Clin Med 2019;8:E657. [PMID: 31083485 DOI: 10.3390/jcm8050657] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
7 Muhsen K, Sinnreich R, Merom D, Beer-Davidson G, Nassar H, Cohen D, Kark JD. Prevalence and determinants of serological evidence of atrophic gastritis among Arab and Jewish residents of Jerusalem: a cross-sectional study. BMJ Open 2019;9:e024689. [PMID: 30700483 DOI: 10.1136/bmjopen-2018-024689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Barchi A, Miraglia C, Violi A, Cambiè G, Nouvenne A, Capasso M, Leandro G, Meschi T, De' Angelis GL, Di Mario F. A non-invasive method for the diagnosis of upper GI diseases. Acta Biomed 2018;89:40-3. [PMID: 30561417 DOI: 10.23750/abm.v89i8-S.7917] [Reference Citation Analysis]
9 Su W, Zhou B, Qin G, Chen Z, Geng X, Chen X, Pan W. Low PG I/II ratio as a marker of atrophic gastritis: Association with nutritional and metabolic status in healthy people. Medicine (Baltimore) 2018;97:e10820. [PMID: 29768385 DOI: 10.1097/MD.0000000000010820] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Kim JH, Lee SY, Lee SP, Kim JH, Sung IK, Park HS, Shim CS, Han HS. The histologic detection of Helicobacter pylori in seropositive subjects is affected by pathology and secretory ability of the stomach. Helicobacter 2018;23:e12480. [PMID: 29520884 DOI: 10.1111/hel.12480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Toyoshima O, Tanikawa C, Yamamoto R, Watanabe H, Yamashita H, Sakitani K, Yoshida S, Kubo M, Matsuo K, Ito H, Koike K, Seto Y, Matsuda K. Decrease in PSCA expression caused by Helicobacter pylori infection may promote progression to severe gastritis. Oncotarget. 2018;9:3936-3945. [PMID: 29423095 DOI: 10.18632/oncotarget.23278] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
12 Moon HW, Lee SY, Hur M, Yun YM. Characteristics of Helicobacter pylori-seropositive subjects according to the stool antigen test findings: a prospective study. Korean J Intern Med. 2018;33:893-901. [PMID: 29061033 DOI: 10.3904/kjim.2016.353.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Moon HW, Lee SY, Hur M, Yun YM. Characteristics of Helicobacter pylori-seropositive subjects according to the stool antigen test findings: a prospective study. Korean J Intern Med 2018;33:893-901. [PMID: 29061033 DOI: 10.3904/kjim.2016.353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Lee SP, Lee SY, Kim JH, Sung IK, Park HS, Shim CS. Link between Serum Pepsinogen Concentrations and Upper Gastrointestinal Endoscopic Findings. J Korean Med Sci 2017;32:796-802. [PMID: 28378553 DOI: 10.3346/jkms.2017.32.5.796] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
15 Kwon Y, Jeon S, Nam S, Shin I. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection. Aliment Pharmacol Ther. 2017;46:758-767. [PMID: 28799258 DOI: 10.1111/apt.14263] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
16 Zagari RM, Rabitti S, Greenwood DC, Eusebi LH, Vestito A, Bazzoli F. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017;46:657-667. [PMID: 28782119 DOI: 10.1111/apt.14248] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 14.0] [Reference Citation Analysis]
17 Nam SY, Jeon SW, Lee HS, Kwon YH, Park H, Choi JW. Long-term follow-up of pepsinogen I/II ratio after eradication of Helicobacter pylori in patients who underwent endoscopic mucosal resection for gastric cancer. Digestive and Liver Disease 2017;49:500-6. [DOI: 10.1016/j.dld.2016.12.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
18 Wang X, Ling L, Li S, Qin G, Cui W, Li X, Ni H. The Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis: A Meta-Analysis. Medicine (Baltimore) 2016;95:e3599. [PMID: 27149493 DOI: 10.1097/MD.0000000000003599] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
19 Tsai KF, Liou JM, Chen MJ, Chen CC, Kuo SH, Lai IR, Yeh KH, Lin MT, Wang HP, Cheng AL, Lin JT, Shun CT, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer. PLoS One. 2017;12:e0170942. [PMID: 28152027 DOI: 10.1371/journal.pone.0170942] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
20 Huang YK, Yu JC, Kang WM, Ma ZQ, Ye X, Tian SB, Yan C. Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis. PLoS One. 2015;10:e0142080. [PMID: 26556485 DOI: 10.1371/journal.pone.0142080] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 8.3] [Reference Citation Analysis]
21 Li JJ, Qi RZ, Ng GK, Xie D. Proteomics in gastric cancer research: Benefits and challenges. Proteomics Clin Appl. 2009;3:185-196. [PMID: 26238618 DOI: 10.1002/prca.200800151] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
22 McNicholl AG, Forné M, Barrio J, De la Coba C, González B, Rivera R, Esteve M, Fernandez-Bañares F, Madrigal B, Gras-Miralles B, Perez-Aisa A, Viver-Pi-Sunyer JM, Bory F, Rosinach M, Loras C, Esteban C, Santolaria S, Gomollon F, Valle J, Gisbert JP; Helicobacter pylori Study Group of Asociación Española de Gastroenterología (AEG). Accuracy of GastroPanel for the diagnosis of atrophic gastritis. Eur J Gastroenterol Hepatol 2014;26:941-8. [PMID: 25014624 DOI: 10.1097/MEG.0000000000000132] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
23 Compare D, Rocco A, Nardone G. Screening for and surveillance of gastric cancer. World J Gastroenterol 2014; 20(38): 13681-13691 [PMID: 25320506 DOI: 10.3748/wjg.v20.i38.13681] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
24 Yakut M, Örmeci N, Erdal H, Keskin O, Karayel Z, Tutkak H, Soykan I. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status. Clin Res Hepatol Gastroenterol. 2013;37:302-311. [PMID: 23137754 DOI: 10.1016/j.clinre.2012.09.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
25 Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O'Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; European Society of Gastrointestinal Endoscopy., European Helicobacter Study Group., European Society of Pathology., Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74-94. [PMID: 22198778 DOI: 10.1055/s-0031-1291491] [Cited by in Crossref: 428] [Cited by in F6Publishing: 380] [Article Influence: 38.9] [Reference Citation Analysis]
26 Dinis-ribeiro M, Areia M, de Vries AC, Marcos-pinto R, Monteiro-soares M, O’connor A, Pereira C, Pimentel-nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-budnik T, Megraud F, Miki K, O’morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; on behalf of MAPS Participants. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch 2012;460:19-46. [DOI: 10.1007/s00428-011-1177-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
27 Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, Janciauskas D, Kuidelis G, Chiu HM, Lin JT. Value of gastrin-17 in detecting antral atrophy. Adv Med Sci 2011;56:145-50. [PMID: 22037174 DOI: 10.2478/v10039-011-0040-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
28 Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Shakeri R, Persson EC, Islami F, Kamangar F, Abnet CC, Boffetta P, Engstrand L, Dawsey SM, Malekzadeh R, Ye W. Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis. PLoS One 2011;6:e26957. [PMID: 22066020 DOI: 10.1371/journal.pone.0026957] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
29 Peitz U, Wex T, Vieth M, Stolte M, Willich S, Labenz J, Jaspersen D, Lind T, Malfertheiner P. Correlation of serum pepsinogens and gastrin-17 with atrophic gastritis in gastroesophageal reflux patients: a matched-pairs study. J Gastroenterol Hepatol 2011;26:82-9. [PMID: 21175799 DOI: 10.1111/j.1440-1746.2010.06413.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
30 Jung SH, Chung WC, Lee KM, Paik CN, Jung JH, Lee MK, Lee YK, Chung IS. Risk factors in malignant transformation of gastric epithelial neoplasia categorized by the revised Vienna classification: endoscopic, pathological, and immunophenotypic features. Gastric Cancer. 2010;13:123-130. [PMID: 20602200 DOI: 10.1007/s10120-010-0550-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
31 Lahner E, Bernardini G, Santucci A, Annibale B. Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype. Expert Rev Proteomics. 2010;7:239-248. [PMID: 20377390 DOI: 10.1586/epr.10.5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
32 Shin CM, Kim N, Lee HS, Lee HE, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC, Song IS. Validation of diagnostic tests for Helicobacter pylori with regard to grade of atrophic gastritis and/or intestinal metaplasia. Helicobacter. 2009;14:512-519. [PMID: 19889068 DOI: 10.1111/j.1523-5378.2009.00726.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
33 Lewerin C, Jacobsson S, Lindstedt G, Nilsson-ehle H. Serum biomarkers for atrophic gastritis and antibodies against Helicobacter pylori in the elderly: Implications for vitamin B 12 , folic acid and iron status and response to oral vitamin therapy. Scandinavian Journal of Gastroenterology 2009;43:1050-6. [DOI: 10.1080/00365520802078341] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
34 Shimoyama T, Oyama T, Matsuzaka M, Danjo K, Nakaji S, Fukuda S. Comparison of a stool antigen test and serology for the diagnosis of Helicobacter pylori infection in mass survey. Helicobacter. 2009;14:87-90. [PMID: 19298335 DOI: 10.1111/j.1523-5378.2009.00672.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
35 van Marrewijk CJ, van Oijen MG, Paloheimo LI, Fransen GA, Mujakovic S, Muris JW, Numans ME, De Wit NJ, Grobbee DE, Knottnerus JA, Laheij RJ, Jansen JB. Influence of gastric mucosal status on success of stepwise acid suppressive therapy for dyspepsia. Aliment Pharmacol Ther 2009;30:82-9. [PMID: 19309389 DOI: 10.1111/j.1365-2036.2009.04001.x] [Reference Citation Analysis]
36 Monkemuller K, Neumann H, Nocon M, Vieth M, Labenz J, Willich SN, Stolte M, Hocker M, Jaspersen D, Lind T, Malfertheiner P. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study. Aliment Pharmacol Ther 2008;28:491-6. [PMID: 18557987 DOI: 10.1111/j.1365-2036.2008.03769.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
37 di Mario F, Cavallaro LG. Non-invasive tests in gastric diseases. Dig Liver Dis. 2008;40:523-530. [PMID: 18439884 DOI: 10.1016/j.dld.2008.02.028] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 4.6] [Reference Citation Analysis]
38 Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, Rafiee R, Shahidi SM, Nikbin B, Khosravi F, Massarrat S. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis. Clin Gastroenterol Hepatol 2008;6:174-9. [PMID: 18237867 DOI: 10.1016/j.cgh.2007.11.016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
39 Rugge M. Secondary prevention of gastric cancer. Gut 2007;56:1646-7. [PMID: 17998318 DOI: 10.1136/gut.2007.133926] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
40 Zhang Z, Sun LP, Gong YH, Wang XG, Zhang M, Yuan Y. Factors affecting the serum gastrin 17 level: an evidence-based analysis of 3906 serum samples among Chinese. J Dig Dis 2007;8:72-6. [DOI: 10.1111/j.1443-9573.2007.00288.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
41 Plebani M, Basso D. Non-invasive assessment of chronic liver and gastric diseases. Clin Chim Acta. 2007;381:39-49. [PMID: 17374528 DOI: 10.1016/j.cca.2007.02.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
42 Rollan A, Ferreccio C, Gederlini A, Serrano C, Torres J, Harris P. Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer. World J Gastroenterol 2006; 12(44): 7172-7178 [PMID: 17131482 DOI: 10.3748/wjg.v12.i44.7172] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
43 Hashemi MR, Rahnavardi M, Bikdeli B, Zahedani MD. H pylori infection among 1000 southern Iranian dyspeptic patients. World J Gastroenterol 2006; 12(34): 5479-5482 [PMID: 17006984 DOI: 10.3748/wjg.v12.i34.5479] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]